American Biogenetic regulatory update

MABXA said Trinity College (Dublin, Ireland) received U.S. Patent No. 5,492,812 covering a diagnostic for Alzheimer's disease that screens tau-peptides in blood. MABXA, the worldwide licensee to the p...